TY  - CONF

T1  - A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer.

JO  - Journal of Clinical Oncology

PY  - 2013/06/20

AU  - Middleton GW

AU  - Valle JW

AU  - Wadsley J

AU  - Propper D

AU  - Coxon FY

AU  - Ross PJ

AU  - Madhusudan S

AU  - Roques T

AU  - Cunningham D

AU  - Corrie P

AU  - Greenhalf W et al

ED  - 

DO  - DOI: 10.1200/jco.2013.31.18_suppl.lba4004

PB  - American Society of Clinical Oncology (ASCO)

VL  - 31

IS  - 18_suppl

SP  - LBA4004

EP  - LBA4004

Y2  - 2025/05/18

ER  -